Citation Impact
Citing Papers
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns
2010 Standout
Factors Influencing the Composition of the Intestinal Microbiota in Early Infancy
2006 Standout
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Altered vagal and intestinal mechanosensory function in chronic unexplained dyspepsia
1998
Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus
1994
Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Identification of tissue transglutaminase as the autoantigen of celiac disease
1997 Standout
Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans1
2002
Bacteriocins: developing innate immunity for food
2005 Standout
Functional Gastroduodenal Disorders
2006 Standout
AGA technical review: Evaluation of dyspepsia
1998
Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
1995
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Chitosan-based hydrogels for controlled, localized drug delivery
2009 Standout
Acetylation of or beta-cyclodextrin addition to potato beneficial effect on glucose metabolism and appetite sensations
1997
Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation
2006
Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer
2012 Standout
Inability ofLactobacillus caseiStrain GG,L. acidophilus, andBifidobacterium bifidumto Degrade Intestinal Mucus Glycoproteins
1995
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Evaluation of colonic sensory thresholds in IBS patients using a barostat
1994
Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome
2010
The 5-HT 3 receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat
2000
Crohn's disease
2012 Standout
Seeking Medical Consultation: Perceptual and Behavioral Characteristics Distinguishing Consulters and Nonconsulters With Functional Dyspepsia
2000
Pathophysiology and treatment of functional dyspepsia
2004
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
2000 Standout
Celiac Disease
2007 Standout
The Immunobiology of Eosinophils
1991
Functional Gut Disorders
1998
Selective dysfunction of mechanosensitive intestinal afferents in irritable bowel syndrome
1995
Gastric distention correlates with activation of multiple cortical and subcortical regions
2001
Potential of using lactic acid bacteria for therapy and immunomodulation in man
1993
Irritable bowel syndrome and dyspepsia in the general population: Overlap and lack of stability over time
1995
Inflammatory Bowel Disease
1991 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Enhanced Local Production of Complement Components in the Small Intestines of Patients with Crohn's Disease
1990
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
Crohn's disease
2016 Standout
Basic and clinical aspects of visceral hyperalgesia
1994
Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?
2002
Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of Prebiotics
1995 Standout
Soluble markers of allergic inflammation
1994
Naturally occurring antibodies devoid of light chains
1993 StandoutNature
Molecular, functional, and pharmacological targets for the development of gut promotility drugs
2006
Alosetron does not affect the visceral perception of gastric distension in healthy subjects
1994
Effects of Tropisetron, a 5-HT<sub>3</sub> Receptor Antagonist, on Proximal Gastric Motor and Sensory Function in Nonulcer Dyspepsia
1999
Abnormalities of the Electrogastrogram in Functional Gastrointestinal Disorders
1999
Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia
1996
Gut flora in health and disease
2003 Standout
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Visceral Hypersensitivity
2005
3 Is functional dyspepsia just a subset of the irritable bowel syndrome?
1998
Review article: bifidobacteria as probiotic agents – physiological effects and clinical benefits
2005
Macrophage plasticity and polarization: in vivo veritas
2012 Standout
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Childhood Functional Gastrointestinal Disorders: Child/Adolescent
2006 Standout
Polysaccharides in colon-specific drug delivery
2001
Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
2009 Standout
Cytotoxic T-cell and NK-cell Lymphomas
2014
Modulation of the fecal microbiota by the intake of aLactobacillus johnsoniiLa1-containing product in human volunteers
2005
AGA technical review on irritable bowel syndrome
2002 Standout
Pharmaceutical Applications of Cyclodextrins. III. Toxicological Issues and Safety Evaluation
1997
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Bioactive peptides of animal origin: a review
2015
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Antidepressants for functional gastrointestinal syndromes
1994
A dose‐ranging, placebo‐controlled, randomized trial of alosetron in patients with functional dyspepsia
2001
The pros, cons, and many unknowns of probiotics
2019 Standout
Visceral perception in irritable bowel syndrome
1995
Efficacy of cisapride therapy in functional dyspepsia
1995
Regional brain activation during proximal stomach distention in humans: A positron emission tomography study
2005
Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia
2001
Functional dyspepsia: evaluation and treatment
2003
Ecological control of the gastrointestinal tract. The role of probiotic flora
1998
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
The proximal stomach and postprandial symptoms in functional dyspeptics
2002
Breastfeeding and the Use of Human Milk
2012 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Methotrexate for induction of remission in refractory Crohn's disease
2014
Short-Chain Fatty Acids and Human Colonic Function: Roles of Resistant Starch and Nonstarch Polysaccharides
2001 Standout
Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice
2008 Standout
In-vitro Evaluation of Biphenylyl Acetic Acid-β-Cyclodextrin Conjugates as Colon-targeting Prodrugs: Drug Release Behaviour in Rat Biological Media
1996
Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma
1983 Standout
Heavy Chain Diseases: Current Findings and Concepts
1979
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
2004
Colonic Eosinophilic Inflammation in Experimental Colitis Is Mediated by Ly6Chigh CCR2+ Inflammatory Monocyte/Macrophage-Derived CCL11
2011
Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease
1999
Gluten, major histocompatibility complex, and the small intestine
1992 Standout
Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue').
1992 Standout
Methotrexate for maintenance of remission in Crohn's disease
2014
Cyclodextrin Drug Carrier Systems
1998 Standout
Deletions in immunoglobulin mu chains.
1982 StandoutNobel
Introduction to the human gut microbiota
2017 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon.
2007
Human Chemokines: An Update
1997 Standout
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Bioactive peptides: Production and functionality
2006
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Versatile Peptide C-Terminal Functionalization via a Computationally Engineered Peptide Amidase
2016 StandoutNobel
Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans
2001
Indolent T-cell lymphoproliferative disease of the gastrointestinal tract
2013
Expression of a Functional Eotaxin (CC Chemokine Ligand 11) Receptor CCR3 by Human Dendritic Cells
2002 StandoutNobel
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
6A-O-[(4-Biphenylyl)acetyl]-α-, -β-, and -γ-cyclodextrins and6A-Deoxy-6A-[[(4-biphenylyl)acetyl]amino]-α-, -β-, and -γ-cyclodextrins: Potential Prodrugs for Colon-Specific Delivery
1997
Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV
2016 Standout
Works of J.C. Rambaud being referenced
The clinicopathological features of extensive small intestinal CD4 T cell infiltration
1999
Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with a new chromosomal translocation
1994
Casein peptide release and passage to the blood in humans during digestion of milk or yogurt
1998
Fate of β-Cyclodextrin in the Human Intestine
1993
Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome
1991
Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: Studies on the secretion rate and immunohistochemical localization of granulocyte granule constituents
1989
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk
1992
Ileal tone in humans: effects of locoregional distensions and eating
1994
Clinico-Pathological Study of a Patient with “Mediterranean” Type of Abdominal Lymphoma and a New Type of IgA Abnormality (“Alpha Chain Disease”)
1968
Methotrexate in Crohn?s disease: long-term efficacy and toxicity
2000
[Survival of Lactobacillus acidophilus and Bifidobacterium sp. in the small intestine following ingestion in fermented milk. A rational basis for the use of probiotics in man].
1992
Abnormal perception of visceral pain in response to gastric distension in chronic idiopathic dyspepsia
1991
Isolement des bifidobacteries dans les selles apres ingestion prolongee de lait au bifidus (LB)
1990
Alpha-Chain Disease
1976